Yupelri Not Superior to Spiriva in Phase 4 Trial
Theravance Biopharma's COPD treatment Yupelri was not superior to Boehringer Ingelheim's Spiriva Handihaler, according to results from a phase 4 study reported by Theravance.
Tag: Spiriva tiotropium
Yupelri Not Superior to Spiriva in Phase 4 Trial
Theravance Biopharma’s COPD treatment Yupelri was not superior to Boehringer Ingelheim’s Spiriva Handihaler, according to results from a phase 4 study reported by Theravance.
Read More
Investigating Tiotropium as an Asthma Treatment
For asthma patients who remain symptomatic despite current treatment options, clinical trials looking at the effectiveness of an add-on aerosol therapy using tiotropium could provide potential relief.
Read More
FDA Approves Spiriva HandiHaler to Reduce COPD Exacerbations
This is the second FDA-approved indication for Spiriva Handihaler, which was already approved as a once-daily treatment for breathing problems associated with COPD.
Read More